Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
PR Newswire•28/10/2026•07:00 ET
0
Key Highlights
- ➤Genprex (GNPX) will present TUSC2 research at GSA’s 2026 Annual Scientific Meeting.
- ➤Research examines TUSC2’s role in mitochondrial biology, cellular resilience, and aging-related processes.
- ➤Poster presentation scheduled November 4, 2026, by Genprex Chief Medical Officer Mark S. Berger.
- ➤Meharry collaboration may inform future REQORSA applications beyond oncology, pending additional research.
Expert Statements
Ryan Confer, President and Chief Executive Officer of Genprex
“Through our collaboration with Meharry Medical College, we are continuing to build our understanding of the TUSC2 gene used in REQORSA and its potential relevance to biological processes beyond cancer”
Ryan Confer, President and Chief Executive Officer of Genprex
“The research into mitochondrial biology and cellular aging is particularly interesting because it may help identify opportunities for further scientific investigation.”
Ryan Confer, President and Chief Executive Officer of Genprex
“We believe this collaboration provides an important opportunity to explore the broader potential future therapeutic applications of REQORSA.”
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting PR Newswire
Research explores the role of TUSC2, the therapeutic gene used in Reqorsa® Gene Therapy in mitochondrial biology and cellular aging, supporting investigation of potential applications beyond oncology
Get started
Create a free account to read the full story.